Isopulegol
CAS 89-79-2
Isopulegol (CAS 89-79-2) is a pharmaceutical compound with 1 bioactivity target and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | MIC | 200 ug.mL-1 | 2 | - |
IUPHAR Ligand-Target Data
Curated ligand-target interaction rows with action, affinity, and literature identifiers.
| Target | Action | Affinity | PubMed |
|---|---|---|---|
| TRPM8 Trpm8 |
Partial agonist | 4.2 pEC50 | 14757700 |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Isopulegol used for in pharmaceutical contexts?
Isopulegol (CAS 89-79-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Isopulegol?
No adverse-event association or SIDER side-effect rows are rendered for Isopulegol in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Isopulegol also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Isopulegol with EU status "restricted".
What clinical phase is Isopulegol in?
No phase 1-4 clinical development badge is rendered for Isopulegol because the matched compound identifier rows do not contain a max-phase value.